ABS Biotechnologies GmbH specializes in biotechnology solutions, focusing on a drug screening platform that addresses challenges not met by existing compound screening technologies. This innovative approach involves the use of blood vessel cells to enhance the precision of drug screening processes. The company aims to contribute to the field of precision medicine by offering technologies that improve the safety and efficacy of drug delivery. With a team led by experts in the life sciences and healthcare sector, ABS Biotechnologies GmbH is committed to advancing research and development in biotechnology to meet the needs of the medical and pharmaceutical industries.
